Similar distribution of orally administered eicosapentaenoic acid and M2 macrophage marker in the hypoperfusion-induced abdominal aortic aneurysm wall

Abdominal aortic aneurysm (AAA) is an aortic disease in which the aortic diameter is ≥3.0 cm; if left untreated, the aortic wall continues to weaken, resulting in progressive dilatation. Effective therapeutic drugs for AAA patients have not been discovered. Eicosapentaenoic acid (EPA) reportedly att...

Full description

Saved in:
Bibliographic Details
Published inFood & function Vol. 12; no. 8; pp. 3469 - 3475
Main Authors Fujishima, Rena, Kugo, Hirona, Yanagimoto, Kenichi, Enomoto, Hirofumi, Moriyama, Tatsuya, Zaima, Nobuhiro
Format Journal Article
LanguageEnglish
Published England Royal Society of Chemistry 21.04.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abdominal aortic aneurysm (AAA) is an aortic disease in which the aortic diameter is ≥3.0 cm; if left untreated, the aortic wall continues to weaken, resulting in progressive dilatation. Effective therapeutic drugs for AAA patients have not been discovered. Eicosapentaenoic acid (EPA) reportedly attenuates the development of AAA in experimental AAA animal models. However, the underlying mechanism of action is still not totally clear. To understand the mechanism, we visualized the distribution of EPA-containing phosphatidylcholine (PC) in the AAA wall by matrix-assisted laser desorption ionization-mass spectrometry imaging. EPA-containing PC was characteristically distributed in the AAA wall, and the positive area for the M2 macrophage marker was significantly higher in the region where EPA-containing PC was highly detected (region 2) than in the region where EPA-containing PC was poorly detected (region 1). The M1 macrophage marker levels were not different between regions 1 and 2. A comparative observation showed a similar distribution of the M2 macrophage marker and EPA-containing PC. These data suggest the preferential incorporation of EPA into M2 macrophages. Positive areas for matrix metalloproteinase 2 and malondialdehyde in region 2 were significantly lower than those in region 1. The reported suppressive effect of EPA on the development of AAA may be partly attributed to the increased anti-inflammatory property of M2 macrophages. EPA-containing PC was characteristically distributed in the AAA wall, and the positive area for the M2 macrophage marker was similar to the distribution of EPA-containing PC.
AbstractList Abdominal aortic aneurysm (AAA) is an aortic disease in which the aortic diameter is ≥3.0 cm; if left untreated, the aortic wall continues to weaken, resulting in progressive dilatation. Effective therapeutic drugs for AAA patients have not been discovered. Eicosapentaenoic acid (EPA) reportedly attenuates the development of AAA in experimental AAA animal models. However, the underlying mechanism of action is still not totally clear. To understand the mechanism, we visualized the distribution of EPA-containing phosphatidylcholine (PC) in the AAA wall by matrix-assisted laser desorption ionization-mass spectrometry imaging. EPA-containing PC was characteristically distributed in the AAA wall, and the positive area for the M2 macrophage marker was significantly higher in the region where EPA-containing PC was highly detected (region 2) than in the region where EPA-containing PC was poorly detected (region 1). The M1 macrophage marker levels were not different between regions 1 and 2. A comparative observation showed a similar distribution of the M2 macrophage marker and EPA-containing PC. These data suggest the preferential incorporation of EPA into M2 macrophages. Positive areas for matrix metalloproteinase 2 and malondialdehyde in region 2 were significantly lower than those in region 1. The reported suppressive effect of EPA on the development of AAA may be partly attributed to the increased anti-inflammatory property of M2 macrophages.
Abdominal aortic aneurysm (AAA) is an aortic disease in which the aortic diameter is ≥3.0 cm; if left untreated, the aortic wall continues to weaken, resulting in progressive dilatation. Effective therapeutic drugs for AAA patients have not been discovered. Eicosapentaenoic acid (EPA) reportedly attenuates the development of AAA in experimental AAA animal models. However, the underlying mechanism of action is still not totally clear. To understand the mechanism, we visualized the distribution of EPA-containing phosphatidylcholine (PC) in the AAA wall by matrix-assisted laser desorption ionization-mass spectrometry imaging. EPA-containing PC was characteristically distributed in the AAA wall, and the positive area for the M2 macrophage marker was significantly higher in the region where EPA-containing PC was highly detected (region 2) than in the region where EPA-containing PC was poorly detected (region 1). The M1 macrophage marker levels were not different between regions 1 and 2. A comparative observation showed a similar distribution of the M2 macrophage marker and EPA-containing PC. These data suggest the preferential incorporation of EPA into M2 macrophages. Positive areas for matrix metalloproteinase 2 and malondialdehyde in region 2 were significantly lower than those in region 1. The reported suppressive effect of EPA on the development of AAA may be partly attributed to the increased anti-inflammatory property of M2 macrophages. EPA-containing PC was characteristically distributed in the AAA wall, and the positive area for the M2 macrophage marker was similar to the distribution of EPA-containing PC.
Author Moriyama, Tatsuya
Kugo, Hirona
Zaima, Nobuhiro
Yanagimoto, Kenichi
Enomoto, Hirofumi
Fujishima, Rena
AuthorAffiliation Food Function R&D Center
Division of Integrated Science and Engineering
Teikyo University
Department of Applied Biological Chemistry
Kindai University
Graduate School of Science and Engineering
Advanced Instrumental Analysis Center
Department of Biosciences
Faculty of Science and Engineering
Nippon Suisan Kaisha
Agricultural Technology and Innovation Research Institute
Ltd
AuthorAffiliation_xml – name: Department of Biosciences
– name: Teikyo University
– name: Faculty of Science and Engineering
– name: Agricultural Technology and Innovation Research Institute
– name: Advanced Instrumental Analysis Center
– name: Division of Integrated Science and Engineering
– name: Ltd
– name: Food Function R&D Center
– name: Kindai University
– name: Graduate School of Science and Engineering
– name: Department of Applied Biological Chemistry
– name: Nippon Suisan Kaisha
Author_xml – sequence: 1
  givenname: Rena
  surname: Fujishima
  fullname: Fujishima, Rena
– sequence: 2
  givenname: Hirona
  surname: Kugo
  fullname: Kugo, Hirona
– sequence: 3
  givenname: Kenichi
  surname: Yanagimoto
  fullname: Yanagimoto, Kenichi
– sequence: 4
  givenname: Hirofumi
  surname: Enomoto
  fullname: Enomoto, Hirofumi
– sequence: 5
  givenname: Tatsuya
  surname: Moriyama
  fullname: Moriyama, Tatsuya
– sequence: 6
  givenname: Nobuhiro
  surname: Zaima
  fullname: Zaima, Nobuhiro
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33900315$$D View this record in MEDLINE/PubMed
BookMark eNpdkU1rFTEUhoNUbK3duFcCboowmknmK0uprYqVLlRwN5xJTrxpZ5JpMoPcP-Lv9VxvW8FscsJ5eJKc9yk7CDEgY89L8aYUSr-1wkWhVNnePGJHUlSyaGrx4-C-rnRzyE5yvha0lNad7p6wQ6U0ncr6iP3-6ic_QuLW5yX5YV18DDw6HhOM45aDnXygFia0HL2JGWYMC2CI3nAw3nIIln-RfAKT4ryBn0hlusHEfeDLBvlmO8cZk1szqQsf7GrIBYONpIaRQ0zLzhVwTds88V908TP22MGY8eRuP2bfL86_nX0sLq8-fDp7d1mYSqilaJ2VqhnqrqylriurnCS3USC0a7WwdeekploPxhjU1kJnKmxaI0CCHlp1zE733jnF2xXz0k8-GxxHek1ccy_rsmtl03Q79NV_6HVcE31gT5VKClkR9XpP0TByTuj6OXmax7YvRb8LrH8vLq7-BvaZ4Jd3ynWY0D6g9_EQ8GIPpGweuv8SV38AY6Cfjw
CitedBy_id crossref_primary_10_1016_j_crfs_2021_11_006
crossref_primary_10_3177_jnsv_68_S143
crossref_primary_10_5650_jos_ess22322
crossref_primary_10_1016_j_jlr_2022_100200
crossref_primary_10_3390_biom13050784
crossref_primary_10_5650_jos_ess23269
crossref_primary_10_1039_D2FO01102F
crossref_primary_10_1371_journal_pone_0305265
Cites_doi 10.1016/j.ejphar.2015.11.001
10.1016/j.atherosclerosis.2011.03.044
10.3390/molecules25102373
10.1038/nm.2711
10.1016/j.ijcard.2015.08.053
10.1371/journal.pone.0134386
10.1371/journal.pone.0165132
10.1042/CS20070352
10.1161/ATVBAHA.115.305269
10.1016/j.clnu.2018.08.007
10.1159/000481780
10.1016/j.plefa.2017.02.001
10.1253/circj.CJ-14-0471
10.1128/JVI.73.7.5548-5555.1999
10.1006/bbrc.1996.1857
10.5551/jat.38315
10.1080/09168451.2016.1146073
10.3390/ijms11125040
10.1039/C7FO00553A
10.1038/srep31268
10.1371/journal.pone.0096286
10.5650/jos.ess17264
10.1159/000362123
10.2353/ajpath.2010.091082
ContentType Journal Article
Copyright Copyright Royal Society of Chemistry 2021
Copyright_xml – notice: Copyright Royal Society of Chemistry 2021
DBID NPM
AAYXX
CITATION
7T5
7T7
7TO
7U7
8FD
C1K
FR3
H94
P64
7X8
DOI 10.1039/d0fo03317k
DatabaseName PubMed
CrossRef
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Oncogenes and Growth Factors Abstracts
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
Oncogenes and Growth Factors Abstracts
Technology Research Database
Toxicology Abstracts
AIDS and Cancer Research Abstracts
Immunology Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList Oncogenes and Growth Factors Abstracts

PubMed
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Diet & Clinical Nutrition
EISSN 2042-650X
EndPage 3475
ExternalDocumentID 10_1039_D0FO03317K
33900315
d0fo03317k
Genre Journal Article
GroupedDBID -
0-7
0R
4.4
53G
705
7~J
AAEMU
AAGNR
AAIWI
AANOJ
ABASK
ABDVN
ABGFH
ABRYZ
ACGFS
ACLDK
ACPRK
ADMRA
ADSRN
AENEX
AFRAH
AFVBQ
AGRSR
AGSTE
AGSWI
ALMA_UNASSIGNED_HOLDINGS
ANUXI
ASKNT
AUDPV
AZFZN
BLAPV
BSQNT
C6K
CKLOX
EBS
ECGLT
EE0
EF-
HZ
H~N
J3I
JG
O-G
O9-
P2P
RCNCU
RIG
RNS
RPMJG
RRC
RSCEA
SKF
SKH
SKJ
SKM
SKR
SKZ
SLC
SLF
---
-JG
0R~
AAHBH
AAJAE
AARTK
AAWGC
AAXHV
ABEMK
ABJNI
ABPDG
ABXOH
AEFDR
AENGV
AESAV
AETIL
AFLYV
AFOGI
AGEGJ
AHGCF
AKBGW
APEMP
GGIMP
H13
HZ~
NPM
RAOCF
RVUXY
AAYXX
CITATION
7T5
7T7
7TO
7U7
8FD
C1K
FR3
H94
P64
7X8
ID FETCH-LOGICAL-c403t-7fd236b58152954d3f2cedc3a09f790d58f2909f9bccce9dda8c4e67c0a2a9b73
ISSN 2042-6496
IngestDate Sat Aug 17 00:33:29 EDT 2024
Thu Oct 10 22:18:43 EDT 2024
Fri Aug 23 00:47:32 EDT 2024
Sat Sep 28 08:23:35 EDT 2024
Sat Apr 09 14:23:26 EDT 2022
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c403t-7fd236b58152954d3f2cedc3a09f790d58f2909f9bccce9dda8c4e67c0a2a9b73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-5515-6019
0000-0002-8242-0628
PMID 33900315
PQID 2518132024
PQPubID 2047526
PageCount 7
ParticipantIDs proquest_journals_2518132024
pubmed_primary_33900315
crossref_primary_10_1039_D0FO03317K
rsc_primary_d0fo03317k
proquest_miscellaneous_2518726687
PublicationCentury 2000
PublicationDate 2021-04-21
PublicationDateYYYYMMDD 2021-04-21
PublicationDate_xml – month: 04
  year: 2021
  text: 2021-04-21
  day: 21
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Cambridge
PublicationTitle Food & function
PublicationTitleAlternate Food Funct
PublicationYear 2021
Publisher Royal Society of Chemistry
Publisher_xml – name: Royal Society of Chemistry
References Yoshihara (D0FO03317K-(cit10)/*[position()=1]) 2015; 79
Keyes (D0FO03317K-(cit21)/*[position()=1]) 2010; 299
Zaima (D0FO03317K-(cit15)/*[position()=1]) 2010; 11
Miyamoto (D0FO03317K-(cit18)/*[position()=1]) 2018; 67
Tanaka (D0FO03317K-(cit6)/*[position()=1]) 2015; 10
Zaima (D0FO03317K-(cit16)/*[position()=1]) 2016; 7
Camandola (D0FO03317K-(cit26)/*[position()=1]) 1996; 229
Kugo (D0FO03317K-(cit24)/*[position()=1]) 2017; 8
Wang (D0FO03317K-(cit23)/*[position()=1]) 2012; 18
Duvall (D0FO03317K-(cit22)/*[position()=1]) 2016; 785
Kugo (D0FO03317K-(cit8)/*[position()=1]) 2016; 80
Aikawa (D0FO03317K-(cit12)/*[position()=1]) 2017; 24
Yamagishi (D0FO03317K-(cit11)/*[position()=1]) 2019; 38
Rubio-Navarro (D0FO03317K-(cit4)/*[position()=1]) 2015; 201
Lindeman (D0FO03317K-(cit2)/*[position()=1]) 2008; 114
Aggarwal (D0FO03317K-(cit1)/*[position()=1]) 2011; 16
Enomoto (D0FO03317K-(cit19)/*[position()=1]) 2020; 25
Kugo (D0FO03317K-(cit5)/*[position()=1]) 2016; 6
Ho (D0FO03317K-(cit20)/*[position()=1]) 2010; 177
Jack (D0FO03317K-(cit9)/*[position()=1]) 2014; 9
Takeshita (D0FO03317K-(cit25)/*[position()=1]) 1999; 73
Kamata (D0FO03317K-(cit7)/*[position()=1]) 2016; 11
Shinto (D0FO03317K-(cit27)/*[position()=1]) 2011; 2011
Zaima (D0FO03317K-(cit13)/*[position()=1]) 2014; 51
Meitala (D0FO03317K-(cit28)/*[position()=1]) 2017; 118
Hashimoto (D0FO03317K-(cit17)/*[position()=1]) 2018; 55
Zaima (D0FO03317K-(cit14)/*[position()=1]) 2011; 217
Dale (D0FO03317K-(cit3)/*[position()=1]) 2015; 35
References_xml – volume: 785
  start-page: 144
  year: 2016
  ident: D0FO03317K-(cit22)/*[position()=1]
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/j.ejphar.2015.11.001
  contributor:
    fullname: Duvall
– volume: 217
  start-page: 427
  year: 2011
  ident: D0FO03317K-(cit14)/*[position()=1]
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2011.03.044
  contributor:
    fullname: Zaima
– volume: 25
  start-page: 2373
  year: 2020
  ident: D0FO03317K-(cit19)/*[position()=1]
  publication-title: Molecules
  doi: 10.3390/molecules25102373
  contributor:
    fullname: Enomoto
– volume: 18
  start-page: 902
  year: 2012
  ident: D0FO03317K-(cit23)/*[position()=1]
  publication-title: Nat. Med.
  doi: 10.1038/nm.2711
  contributor:
    fullname: Wang
– volume: 201
  start-page: 66
  year: 2015
  ident: D0FO03317K-(cit4)/*[position()=1]
  publication-title: Int. J. Cardiol.
  doi: 10.1016/j.ijcard.2015.08.053
  contributor:
    fullname: Rubio-Navarro
– volume: 16
  start-page: 11
  year: 2011
  ident: D0FO03317K-(cit1)/*[position()=1]
  publication-title: Exp. Clin. Cardiol.
  contributor:
    fullname: Aggarwal
– volume: 10
  start-page: e0134386
  year: 2015
  ident: D0FO03317K-(cit6)/*[position()=1]
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0134386
  contributor:
    fullname: Tanaka
– volume: 11
  start-page: e0165132
  year: 2016
  ident: D0FO03317K-(cit7)/*[position()=1]
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0165132
  contributor:
    fullname: Kamata
– volume: 114
  start-page: 687
  year: 2008
  ident: D0FO03317K-(cit2)/*[position()=1]
  publication-title: Clin. Sci.
  doi: 10.1042/CS20070352
  contributor:
    fullname: Lindeman
– volume: 35
  start-page: 1746
  year: 2015
  ident: D0FO03317K-(cit3)/*[position()=1]
  publication-title: Arterioscler., Thromb., Vasc. Biol.
  doi: 10.1161/ATVBAHA.115.305269
  contributor:
    fullname: Dale
– volume: 7
  start-page: 259
  year: 2016
  ident: D0FO03317K-(cit16)/*[position()=1]
  publication-title: Biochem. Biophys. Rep.
  contributor:
    fullname: Zaima
– volume: 38
  start-page: 1678
  issue: 4
  year: 2019
  ident: D0FO03317K-(cit11)/*[position()=1]
  publication-title: Clin. Nutr.
  doi: 10.1016/j.clnu.2018.08.007
  contributor:
    fullname: Yamagishi
– volume: 55
  start-page: 63
  year: 2018
  ident: D0FO03317K-(cit17)/*[position()=1]
  publication-title: J. Vasc. Res.
  doi: 10.1159/000481780
  contributor:
    fullname: Hashimoto
– volume: 118
  start-page: 1
  year: 2017
  ident: D0FO03317K-(cit28)/*[position()=1]
  publication-title: Prostaglandins, Leukotrienes Essent. Fatty Acids
  doi: 10.1016/j.plefa.2017.02.001
  contributor:
    fullname: Meitala
– volume: 79
  start-page: 1470
  year: 2015
  ident: D0FO03317K-(cit10)/*[position()=1]
  publication-title: Circ. J.
  doi: 10.1253/circj.CJ-14-0471
  contributor:
    fullname: Yoshihara
– volume: 73
  start-page: 5548
  year: 1999
  ident: D0FO03317K-(cit25)/*[position()=1]
  publication-title: J. Virol.
  doi: 10.1128/JVI.73.7.5548-5555.1999
  contributor:
    fullname: Takeshita
– volume: 229
  start-page: 643
  year: 1996
  ident: D0FO03317K-(cit26)/*[position()=1]
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1006/bbrc.1996.1857
  contributor:
    fullname: Camandola
– volume: 299
  start-page: H153
  year: 2010
  ident: D0FO03317K-(cit21)/*[position()=1]
  publication-title: Am. J. Physiol.: Heart Circ. Physiol.
  contributor:
    fullname: Keyes
– volume: 24
  start-page: 912
  issue: 9
  year: 2017
  ident: D0FO03317K-(cit12)/*[position()=1]
  publication-title: J. Atheroscler. Thromb.
  doi: 10.5551/jat.38315
  contributor:
    fullname: Aikawa
– volume: 80
  start-page: 1186
  year: 2016
  ident: D0FO03317K-(cit8)/*[position()=1]
  publication-title: Biosci., Biotechnol., Biochem.
  doi: 10.1080/09168451.2016.1146073
  contributor:
    fullname: Kugo
– volume: 11
  start-page: 5040
  year: 2010
  ident: D0FO03317K-(cit15)/*[position()=1]
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms11125040
  contributor:
    fullname: Zaima
– volume: 2011
  start-page: 134592
  year: 2011
  ident: D0FO03317K-(cit27)/*[position()=1]
  publication-title: Autoimmune Dis.
  contributor:
    fullname: Shinto
– volume: 8
  start-page: 2829
  year: 2017
  ident: D0FO03317K-(cit24)/*[position()=1]
  publication-title: Food Funct.
  doi: 10.1039/C7FO00553A
  contributor:
    fullname: Kugo
– volume: 6
  start-page: 31268
  year: 2016
  ident: D0FO03317K-(cit5)/*[position()=1]
  publication-title: Sci. Rep.
  doi: 10.1038/srep31268
  contributor:
    fullname: Kugo
– volume: 9
  start-page: e96286
  year: 2014
  ident: D0FO03317K-(cit9)/*[position()=1]
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0096286
  contributor:
    fullname: Jack
– volume: 67
  start-page: 589
  year: 2018
  ident: D0FO03317K-(cit18)/*[position()=1]
  publication-title: J. Oleo Sci.
  doi: 10.5650/jos.ess17264
  contributor:
    fullname: Miyamoto
– volume: 51
  start-page: 144
  year: 2014
  ident: D0FO03317K-(cit13)/*[position()=1]
  publication-title: J. Vasc. Res.
  doi: 10.1159/000362123
  contributor:
    fullname: Zaima
– volume: 177
  start-page: 2116
  year: 2010
  ident: D0FO03317K-(cit20)/*[position()=1]
  publication-title: Am. J. Pathol.
  doi: 10.2353/ajpath.2010.091082
  contributor:
    fullname: Ho
SSID ssj0000399898
Score 2.3521395
Snippet Abdominal aortic aneurysm (AAA) is an aortic disease in which the aortic diameter is ≥3.0 cm; if left untreated, the aortic wall continues to weaken, resulting...
SourceID proquest
crossref
pubmed
rsc
SourceType Aggregation Database
Index Database
Publisher
StartPage 3469
SubjectTerms Aneurysms
Animal models
Anti-inflammatory agents
Aorta
Aortic aneurysms
Eicosapentaenoic acid
Inflammation
Ionization
Ions
Lecithin
Macrophages
Malondialdehyde
Markers
Mass spectrometry
Mass spectroscopy
Matrix metalloproteinase
Matrix metalloproteinases
Metalloproteinase
Oral administration
Phosphatidylcholine
Title Similar distribution of orally administered eicosapentaenoic acid and M2 macrophage marker in the hypoperfusion-induced abdominal aortic aneurysm wall
URI https://www.ncbi.nlm.nih.gov/pubmed/33900315
https://www.proquest.com/docview/2518132024
https://search.proquest.com/docview/2518726687
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXK9sIL4mtQGMgIxEsVSO2kSR4HW6nY2B7oRHmKnNheA21SdY3Q-CH8IH4Z98bOx9iEgJcoclKnzT21r6_PvYeQF0LxUTrylJN6vnQwbdZJEqkdxYNgKIORF-mKIHs8mpx672f-rNf72WEtlZvkVfr92ryS_7EqtIFdMUv2HyzbdAoNcA72hSNYGI5_ZeOP2TJDFqnE6rdWuAq9P8y6X1wMhC2Mi3KcAwUmPxcrpIqrvMAqrWkmDc2CDZYClbzmyN9ZIl9nXdMf5xerYqXWusSgmgPr9xL5AiKRhREDE8XaVHxVYJvz5eCbWCy6_u4YiyYjunD-7O75j8svGP1aWt81b2aHw_Ksit5OMP-uaf1cySkBrAqbTJSl86xZDeRFfQU_pctl1g1msCHuy7A2mGFCJjVfteKjWNW7dlhkmFAEGLIFtDttvju7NK6zDn7DziDNPaMOYyd87hntliuTicuxFqt0deFycLO-tlNmTRM4PonHp0dH8fRgNr1BthkMduEW2d47fPPuUxPpg25QpBNVDuuvXtfJ5dHrtvvLntGV5Q44P-talKZyfqa3yS27aqF7BoJ3SE_ld0l_H94ffUltadkFPa6VHe6RHxaatAtNWmhqoEm70KS_Q5MiNClAk35gtIUmNdCkWU4BmvRaaNIGmtRAk9bQpAjN--R0fDB9O3GsBAiMHS7fOIGWjI8SPxxWG9KSawZ9pVy4kQ4iV_qhZhGcR0mapiqSUoSpp0ZB6gomoiTgO2QrL3L1kFBXaAb3sTDR3AsVE4Gfgv_NtJa-r6JhnzyvX3-8MpVe4oqhwaN43x2fVEY67JPd2jKxHQnOY1gjhFiKgHl98qy5DMDFzTf4mUVp7gnAGw6DPnlgLNo8hnPcTxj6fbIDJm6aW2g8-vNTH5Ob7Z9pl2xt1qV6Ar7yJnlqwfgLP5vKqA
link.rule.ids 315,783,787,27938,27939
linkProvider Royal Society of Chemistry
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Similar+distribution+of+orally+administered+eicosapentaenoic+acid+and+M2+macrophage+marker+in+the+hypoperfusion-induced+abdominal+aortic+aneurysm+wall&rft.jtitle=Food+%26+function&rft.au=Fujishima%2C+Rena&rft.au=Kugo%2C+Hirona&rft.au=Yanagimoto%2C+Kenichi&rft.au=Enomoto%2C+Hirofumi&rft.date=2021-04-21&rft.pub=Royal+Society+of+Chemistry&rft.issn=2042-6496&rft.eissn=2042-650X&rft.volume=12&rft.issue=8&rft.spage=3469&rft.epage=3475&rft_id=info:doi/10.1039%2Fd0fo03317k&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2042-6496&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2042-6496&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2042-6496&client=summon